{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:28:31Z","timestamp":1790720911843,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,9]]},"DOI":"10.7759\/cureus.41600","type":"journal-article","created":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T14:24:58Z","timestamp":1688912698000},"source":"Crossref","is-referenced-by-count":13,"title":["Bodybuilding: A Comprehensive Review of Performance-Enhancing Substance Use and Public Health Implications"],"prefix":"10.7759","author":[{"given":"Saket","family":"Mantri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sristy","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Yelne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur B","family":"Wanjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Bodybuilding. (2023). Accessed. May 5, 2023: https:\/\/www.britannica.com\/sports\/bodybuilding."},{"key":"ref2","unstructured":"A history lesson in bodybuilding. (2023). Accessed. May 5, 2023: https:\/\/www.bodybuilding.com\/fun\/drobson61.htm."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2006.027573","article-title":"Human growth hormone doping in sport","volume":"40 Suppl 1","author":"Saugy M","year":"2006","unstructured":"Saugy M, Robinson N, Saudan C, Baume N, Avois L, Mangin P. Human growth hormone doping in sport. Br J Sports Med. 2006, 40 Suppl 1:i35-9. 10.1136\/bjsm.2006.027573","journal-title":"Br J Sports Med"},{"key":"ref4","unstructured":"Performance-enhancing drugs. know the risks. (2023). Accessed: May 5, 2023: https:\/\/www.mayoclinic.org\/healthy-lifestyle\/fitness\/in-depth\/performance-enhancing-drugs\/art-20046134."},{"key":"ref5","unstructured":"What is the history of anabolic steroid use?. (2023). Accessed. May 5, 2023: https:\/\/nida.nih.gov\/publications\/research-reports\/steroids-other-appearance-performance-enhancing-drugs-apeds\/what-h...."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/socsci8030080","article-title":"Bodybuilding and fitness doping in transition. Historical transformations and contemporary challenges","volume":"8","author":"Andreasson J","year":"2019","unstructured":"Andreasson J, Johansson T. Bodybuilding and fitness doping in transition. Historical transformations and contemporary challenges. Social Sciences. 2019, 8:80. 10.3390\/socsci8030080","journal-title":"Social Sciences"},{"key":"ref7","article-title":"Performance Enhancing Hormone Doping in Sport","author":"Handelsman DJ","year":"2015","unstructured":"Handelsman DJ. Performance Enhancing Hormone Doping in Sport. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, Inc., South Dartmouth; 2015."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2019.02881","article-title":"Determinants of the intention to use performance-enhancing substances among Portuguese gym users","volume":"10","author":"Tavares AS","year":"2019","unstructured":"Tavares AS, Rosado AF, Mar\u00f4co J, Calmeiro L, Serpa S. Determinants of the intention to use performance-enhancing substances among Portuguese gym users. Front Psychol. 2019, 10:2881. 10.3389\/fpsyg.2019.02881","journal-title":"Front Psychol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1556\/JBA.3.2014.3.6","article-title":"Motivational and psychological correlates of bodybuilding dependence","volume":"3","author":"Emini NN","year":"2014","unstructured":"Emini NN, Bond MJ. Motivational and psychological correlates of bodybuilding dependence. J Behav Addict. 2014, 3:182-8. 10.1556\/JBA.3.2014.3.6","journal-title":"J Behav Addict"},{"key":"ref10","unstructured":"Anabolic steroids. Benefits, risks and legal alternatives. (2023). Accessed: May 5, 2023: https:\/\/www.outlookindia.com\/outlook-spotlight\/anabolic-steroids-benefits-risks-and-legal-alternatives-news-277551."},{"key":"ref11","article-title":"Anabolic Steroid Use Disorder","author":"AlShareef S","year":"2019","unstructured":"AlShareef S, Gokarakonda SB, Marwaha R. Anabolic Steroid Use Disorder. StatPearls Publishing, Treasure Island; 2019."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12610-016-0029-4","article-title":"Anabolic steroids abuse and male infertility","volume":"26","author":"El Osta R","year":"2016","unstructured":"El Osta R, Almont T, Diligent C, Hubert N, Eschw\u00e8ge P, Hubert J. Anabolic steroids abuse and male infertility. Basic Clin Androl. 2016, 26:2. 10.1186\/s12610-016-0029-4","journal-title":"Basic Clin Androl"},{"key":"ref13","article-title":"Doping in sports and its spread to at-risk populations: an international review","volume":"6","author":"Baron DA","year":"2007","unstructured":"Baron DA, Martin DM, Magd SA. Doping in sports and its spread to at-risk populations: an international review. World Psychiatry. 2007, 6:118-23.","journal-title":"World Psychiatry"},{"key":"ref14","article-title":"Normal Physiology of Growth Hormone in Adults","author":"Olarescu NC","year":"2000","unstructured":"Olarescu NC, Gunawardane K, Hansen TK, M\u00f8ller N, J\u00f8rgensen JO. Normal Physiology of Growth Hormone in Adults. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, Inc., South Dartmouth; 2000."},{"key":"ref15","unstructured":"Anabolic steroids. Uses, side effects, and alternatives. (2020). Accessed: May 5, 2023: https:\/\/www.healthline.com\/health\/anabolic-steroids."},{"key":"ref16","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox G","year":"2005","unstructured":"Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005, 26:19-39.","journal-title":"Clin Biochem Rev"},{"key":"ref17","unstructured":"Low blood glucose (Hypoglycemia). (2023). Accessed. May 5, 2023: https:\/\/www.niddk.nih.gov\/health-information\/diabetes\/overview\/preventing-problems\/low-blood-glucose-hypoglycemia."},{"key":"ref18","unstructured":"Hypoglycemia - symptoms and causes. (2023). Accessed. May 5, 2023: https:\/\/www.mayoclinic.org\/diseases-conditions\/hypoglycemia\/symptoms-causes\/syc-20373685."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_329_19","article-title":"Effect of artificial sweeteners on insulin resistance among type-2 diabetes mellitus patients","volume":"9","author":"Mathur K","year":"2020","unstructured":"Mathur K, Agrawal RK, Nagpure S, Deshpande D. Effect of artificial sweeteners on insulin resistance among type-2 diabetes mellitus patients. J Family Med Prim Care. 2020, 9:69-71. 10.4103\/jfmpc.jfmpc_329_19","journal-title":"J Family Med Prim Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S53784","article-title":"Drug abuse in athletes","volume":"5","author":"Reardon CL","year":"2014","unstructured":"Reardon CL, Creado S. Drug abuse in athletes. Subst Abuse Rehabil. 2014, 5:95-105. 10.2147\/SAR.S53784","journal-title":"Subst Abuse Rehabil"},{"key":"ref21","article-title":"Therapeutic Uses of Diuretic Agents","author":"Arumugham VB","year":"2023","unstructured":"Arumugham VB, Shahin MH. Therapeutic Uses of Diuretic Agents. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0109","article-title":"Hypokalemia: a clinical update","volume":"7","author":"Kardalas E","year":"2018","unstructured":"Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: a clinical update. Endocr Connect. 2018, 7:R135-46. 10.1530\/EC-18-0109","journal-title":"Endocr Connect"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ph3072291","article-title":"Nonsteroidal anti-inflammatory drugs and the kidney","volume":"3","author":"H\u00f6rl WH","year":"2010","unstructured":"H\u00f6rl WH. Nonsteroidal anti-inflammatory drugs and the kidney. Pharmaceuticals (Basel). 2010, 3:2291-321. 10.3390\/ph3072291","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13102-021-00296-y","article-title":"Peak week recommendations for bodybuilders: an evidence based approach","volume":"13","author":"Escalante G","year":"2021","unstructured":"Escalante G, Stevenson SW, Barakat C, Aragon AA, Schoenfeld BJ. Peak week recommendations for bodybuilders: an evidence based approach. BMC Sports Sci Med Rehabil. 2021, 13:68. 10.1186\/s13102-021-00296-y","journal-title":"BMC Sports Sci Med Rehabil"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-015-0006-5","article-title":"Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis","volume":"10","author":"Sagoe D","year":"2015","unstructured":"Sagoe D, McVeigh J, Bj\u00f8rnebekk A, Essilfie MS, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abuse Treat Prev Policy. 2015, 10:12. 10.1186\/s13011-015-0006-5","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-12-41","article-title":"Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review","volume":"12","author":"Westover AN","year":"2012","unstructured":"Westover AN, Halm EA. Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review. BMC Cardiovasc Disord. 2012, 12:41. 10.1186\/1471-2261-12-41","journal-title":"BMC Cardiovasc Disord"},{"key":"ref27","article-title":"Energy drink consumption: beneficial and adverse health effects","volume":"9","author":"Alsunni AA","year":"2015","unstructured":"Alsunni AA. Energy drink consumption: beneficial and adverse health effects. Int J Health Sci (Qassim). 2015, 9:468-74.","journal-title":"Int J Health Sci (Qassim)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21163","article-title":"The effect of caffeine and albuterol on body composition and metabolic rate","volume":"23","author":"Liu AG","year":"2015","unstructured":"Liu AG, Arceneaux KP 3rd, Chu JT, et al.. The effect of caffeine and albuterol on body composition and metabolic rate. Obesity (Silver Spring). 2015, 23:1830-5. 10.1002\/oby.21163","journal-title":"Obesity (Silver Spring)"},{"key":"ref29","article-title":"Acne: Overview","author":"Institute for Quality and Efficiency in Health Care","year":"2006","unstructured":"Institute for Quality and Efficiency in Health Care. Acne: Overview. IQWiG, Cologne; 2006."},{"key":"ref30","article-title":"Biochemistry, Dihydrotestosterone","author":"Kinter KJ","year":"2023","unstructured":"Kinter KJ, Anekar AA. Biochemistry, Dihydrotestosterone. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref31","article-title":"Androgenic steroids","author":"National Institute of Diabetes and Digestive and Kidney Diseases","year":"2012","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Androgenic steroids. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet] (ed): NIDDKD, Bethesda; 2012. 1:400."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9333","article-title":"Anabolic steroids and cardiovascular outcomes: the controversy","volume":"12","author":"Perry JC","year":"2020","unstructured":"Perry JC, Schuetz TM, Memon MD, Faiz S, Cancarevic I. Anabolic steroids and cardiovascular outcomes: the controversy. Cureus. 2020, 12:e9333. 10.7759\/cureus.9333","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009040450","article-title":"Development of focal segmental glomerulosclerosis after anabolic steroid abuse","volume":"21","author":"Herlitz LC","year":"2010","unstructured":"Herlitz LC, Markowitz GS, Farris AB, et al.. Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol. 2010, 21:163-72. 10.1681\/ASN.2009040450","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.190002","article-title":"Management of anabolic steroid-induced infertility: novel strategies for fertility maintenance and recovery","volume":"38","author":"Tatem AJ","year":"2020","unstructured":"Tatem AJ, Beilan J, Kovac JR, Lipshultz LI. Management of anabolic steroid-induced infertility: novel strategies for fertility maintenance and recovery. World J Mens Health. 2020, 38:141-50. 10.5534\/wjmh.190002","journal-title":"World J Mens Health"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/med.21476","article-title":"Comprehensive review of cardiovascular toxicity of drugs and related agents","volume":"38","author":"Mlad\u011bnka P","year":"2018","unstructured":"Mlad\u011bnka P, Applov\u00e1 L, Pato\u010dka J, et al.. Comprehensive review of cardiovascular toxicity of drugs and related agents. Med Res Rev. 2018, 38:1332-403. 10.1002\/med.21476","journal-title":"Med Res Rev"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24767","article-title":"Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review","volume":"9","author":"Salerno M","year":"2018","unstructured":"Salerno M, Cascio O, Bertozzi G, et al.. Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review. Oncotarget. 2018, 9:19415-26. 10.18632\/oncotarget.24767","journal-title":"Oncotarget"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00789.x","article-title":"The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis","volume":"161","author":"Cadwallader AB","year":"2010","unstructured":"Cadwallader AB, de la Torre X, Tieri A, Botr\u00e8 F. The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis. Br J Pharmacol. 2010, 161:1-16. 10.1111\/j.1476-5381.2010.00789.x","journal-title":"Br J Pharmacol"},{"key":"ref38","unstructured":"The world anti-doping code. (2023). Accessed. May 5, 2023: https:\/\/www.wada-ama.org\/en\/what-we-do\/world-anti-doping-code."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.5812\/asjsm.35018","article-title":"The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the south of Iran, Bushehr","volume":"7","author":"Haerinejad MJ","year":"2016","unstructured":"Haerinejad MJ, Ostovar A, Farzaneh MR, Keshavarz M. The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the south of Iran, Bushehr. Asian J Sports Med. 2016, 7:e35018. 10.5812\/asjsm.35018","journal-title":"Asian J Sports Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s40798-022-00548-2","article-title":"Recreational athletes\u2019 use of performance-enhancing substances: results from the first European Randomized Response Technique survey","volume":"9","author":"Christiansen AV","year":"2023","unstructured":"Christiansen AV, Frenger M, Chirico A, Pitsch W. Recreational athletes\u2019 use of performance-enhancing substances: results from the first European Randomized Response Technique survey. Sports Med Open. 2023, 9:1. 10.1186\/s40798-022-00548-2","journal-title":"Sports Med Open"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2018.01431","article-title":"Understanding the paths to appearance- and performance-enhancing drug use in bodybuilding","volume":"9","author":"Coquet R","year":"2018","unstructured":"Coquet R, Roussel P, Ohl F. Understanding the paths to appearance- and performance-enhancing drug use in bodybuilding. Front Psychol. 2018, 9:1431. 10.3389\/fpsyg.2018.01431","journal-title":"Front Psychol"},{"key":"ref42","unstructured":"Substandard and falsified medical products. (2023). Accessed. May 5, 2023: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.648467","article-title":"Enhancing the self: Amateur bodybuilders making sense of experiences with appearance and performance-enhancing drugs","volume":"12","author":"Macho J","year":"2021","unstructured":"Macho J, Mudrak J, Slepicka P. Enhancing the self: Amateur bodybuilders making sense of experiences with appearance and performance-enhancing drugs. Front Psychol. 2021, 12:648467. 10.3389\/fpsyg.2021.648467","journal-title":"Front Psychol"},{"key":"ref44","article-title":"Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of Iran","volume":"5","author":"Nakhaee MR","year":"2013","unstructured":"Nakhaee MR, Pakravan F, Nakhaee N. Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of Iran. Addict Health. 2013, 5:77-82.","journal-title":"Addict Health"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-7287.2007.00076.x","article-title":"Are athletes doped? Some theoretical arguments and empirical evidence","volume":"25","author":"Dilger A","year":"2007","unstructured":"Dilger A, Frick B, Tolsdorf F. Are athletes doped? Some theoretical arguments and empirical evidence. Contemporary Economic Policy. 2007, 25:604-15. 10.1111\/j.1465-7287.2007.00076.x","journal-title":"Contemporary Economic Policy"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldn014","article-title":"Doping in competition or doping in sport?","volume":"86","author":"Lippi G","year":"2008","unstructured":"Lippi G, Franchini M, Guidi GC. Doping in competition or doping in sport?. Br Med Bull. 2008, 86:95-107. 10.1093\/bmb\/ldn014","journal-title":"Br Med Bull"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102897","article-title":"Risk and enabling environments in sport: systematic doping as harm reduction","volume":"91","author":"Henning A","year":"2021","unstructured":"Henning A, McLean K, Andreasson J, Dimeo P. Risk and enabling environments in sport: systematic doping as harm reduction. Int J Drug Policy. 2021, 91:102897. 10.1016\/j.drugpo.2020.102897","journal-title":"Int J Drug Policy"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-015-0030-5","article-title":"Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait--a cross-sectional study","volume":"10","author":"Alsaeed I","year":"2015","unstructured":"Alsaeed I, Alabkal JR. Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait--a cross-sectional study. Subst Abuse Treat Prev Policy. 2015, 10:33. 10.1186\/s13011-015-0030-5","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.15171\/apb.2018.062","article-title":"Doping in sports, a never-ending story?","volume":"8","author":"Vlad RA","year":"2018","unstructured":"Vlad RA, Hancu G, Popescu GC, Lungu IA. Doping in sports, a never-ending story?. Adv Pharm Bull. 2018, 8:529-34. 10.15171\/apb.2018.062","journal-title":"Adv Pharm Bull"},{"key":"ref50","unstructured":"Classification of three steroids as Schedule III anabolic steroids under the Controlled Substances Act. (2023). Accessed. May 5, 2023: https:\/\/www.federalregister.gov\/documents\/2009\/12\/04\/E9-28572\/classification-of-three-steroids-as-schedule-iii-anabol...."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2006.027383","article-title":"FIFA's approach to doping in football","volume":"40 Suppl 1","author":"Dvorak J","year":"2006","unstructured":"Dvorak J, Graf-Baumann T, D'Hooghe M, Kirkendall D, Taennler H, Saugy M. FIFA's approach to doping in football. Br J Sports Med. 2006, 40 Suppl 1:i3-i12. 10.1136\/bjsm.2006.027383","journal-title":"Br J Sports Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7445.907","article-title":"Growth hormone: uses and abuses","volume":"328","author":"Hintz RL","year":"2004","unstructured":"Hintz RL. Growth hormone: uses and abuses. BMJ. 2004, 328:907-8. 10.1136\/bmj.328.7445.907","journal-title":"BMJ"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.4103\/jpbs.JPBS_229_17","article-title":"Sports pharmacology: a medical pharmacologist\u2019s perspective","volume":"10","author":"Malve HO","year":"2018","unstructured":"Malve HO. Sports pharmacology: a medical pharmacologist\u2019s perspective. J Pharm Bioallied Sci. 2018, 10:126-36. 10.4103\/jpbs.JPBS_229_17","journal-title":"J Pharm Bioallied Sci"},{"key":"ref54","article-title":"Weight-loss and maintenance strategies","author":"Institute of Medicine (US) Subcommittee on Military Weight Management","year":"2004","unstructured":"Institute of Medicine (US) Subcommittee on Military Weight Management. Weight-loss and maintenance strategies. Weight Management: State of the Science and Opportunities for Military Programs. Management I of M (US) S on MW (ed): National Academies Press (US), Washington (DC); 2004. 1:550."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope HG Jr","year":"2014","unstructured":"Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014, 35:341-75. 10.1210\/er.2013-1058","journal-title":"Endocr Rev"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60809-4","article-title":"Use of mass media campaigns to change health behaviour","volume":"376","author":"Wakefield MA","year":"2010","unstructured":"Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet. 2010, 376:1261-71. 10.1016\/S0140-6736(10)60809-4","journal-title":"Lancet"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-3-7","article-title":"Psychological drivers in doping: the life-cycle model of performance enhancement","volume":"3","author":"Petr\u00f3czi A","year":"2008","unstructured":"Petr\u00f3czi A, Aidman E. Psychological drivers in doping: the life-cycle model of performance enhancement. Subst Abuse Treat Prev Policy. 2008, 3:7. 10.1186\/1747-597X-3-7","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205222","article-title":"Sport motivation and doping in adolescent athletes","volume":"13","author":"Mudrak J","year":"2018","unstructured":"Mudrak J, Slepicka P, Slepickova I. Sport motivation and doping in adolescent athletes. PLoS One. 2018, 13:e0205222. 10.1371\/journal.pone.0205222","journal-title":"PLoS One"},{"key":"ref59","unstructured":"Physical activity. (2023). Accessed. May 5, 2023: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/physical-activity."},{"key":"ref60","unstructured":"Drug use and substance misuse in sports. (2023). Accessed. May 5, 2023: https:\/\/www.gatewayfoundation.org\/addiction-blog\/athletes-drug-abuse\/."},{"key":"ref61","unstructured":"What can be done to prevent steroid misuse?. (2023). Accessed. May 5, 2023: https:\/\/nida.nih.gov\/publications\/research-reports\/steroids-other-appearance-performance-enhancing-drugs-apeds\/what-c...."},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.17226\/5297","article-title":"Pathways of Addiction: Opportunities in Drug Abuse Research","author":"Institute of Medicine (US) Committee on Opportunities in Drug Abuse Research","year":"1996","unstructured":"Institute of Medicine (US) Committee on Opportunities in Drug Abuse Research. Pathways of Addiction: Opportunities in Drug Abuse Research. National Academies Press (US), Washington; 1996. 10.17226\/5297"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2010.04.012","article-title":"Cognitive behavioral therapy for substance use disorders","volume":"33","author":"McHugh RK","year":"2010","unstructured":"McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin North Am. 2010, 33:511-25. 10.1016\/j.psc.2010.04.012","journal-title":"Psychiatr Clin North Am"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-015-0087-5","article-title":"Why the war on drugs in sport will never be won","volume":"12","author":"Smith AC","year":"2015","unstructured":"Smith AC, Stewart B. Why the war on drugs in sport will never be won. Harm Reduct J. 2015, 12:53. 10.1186\/s12954-015-0087-5","journal-title":"Harm Reduct J"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.peh.2016.01.001","article-title":"Doping prevention through anti-doping education and practical strength training: The Hercules program","volume":"5","author":"Sagoe D","year":"2016","unstructured":"Sagoe D, Holden G, Rise ENK, et al.. Doping prevention through anti-doping education and practical strength training: The Hercules program. Performance Enhancement Health. 2016, 5:24-30. 10.1016\/j.peh.2016.01.001","journal-title":"Performance Enhancement Health"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1542\/pir.33-6-265","article-title":"Performance-enhancing drugs","volume":"33","author":"Dandoy C","year":"2012","unstructured":"Dandoy C, Gereige RS. Performance-enhancing drugs. Pediatr Rev. 2012, 33:265-71; quiz 271-2. 10.1542\/pir.33-6-265","journal-title":"Pediatr Rev"},{"key":"ref67","unstructured":"Ethical issues in sports and how athletic leaders can address them. (2023). Accessed. May 5, 2023: https:\/\/onlinemasters.ohio.edu\/blog\/ethical-issues-in-sports\/."},{"key":"ref68","unstructured":"Doping-WADA to reduce bans for recreational drugs from 2021. (2021). Accessed. May 5, 2023: https:\/\/www.reuters.com\/article\/sport-doping-wada-idAFL4N2F84WQ."},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3389\/fspor.2021.673452","article-title":"Efficient ways to combat doping in a sports education context!? A systematic review on doping prevention measures focusing on young age groups","volume":"3","author":"P\u00f6ppel K","year":"2021","unstructured":"P\u00f6ppel K. Efficient ways to combat doping in a sports education context!? A systematic review on doping prevention measures focusing on young age groups. Front Sports Act Living. 2021, 3:673452. 10.3389\/fspor.2021.673452","journal-title":"Front Sports Act Living"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1080\/10888691.2018.1537791","article-title":"Implications for educational practice of the science of learning and development","volume":"24","author":"Darling-Hammond L","year":"2020","unstructured":"Darling-Hammond L, Flook L, Cook-Harvey C, Barron B, Osher D. Implications for educational practice of the science of learning and development. Appl Dev Sci. 2020, 24:97-140. 10.1080\/10888691.2018.1537791","journal-title":"Appl Dev Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/157270-bodybuilding-a-comprehensive-review-of-performance-enhancing-substance-use-and-public-health-implications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:02:32Z","timestamp":1707490952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/157270-bodybuilding-a-comprehensive-review-of-performance-enhancing-substance-use-and-public-health-implications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,9]]},"references-count":70,"URL":"https:\/\/doi.org\/10.7759\/cureus.41600","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,9]]}}}